The University of Oxford plans to test its COVID-19 vaccine in children for the first time, becoming the latest vaccine developer to assess whether its coronavirus shot is effective in young people. The trial announced on Saturday seeks to recruit 300 volunteers between the ages of 6 and 17, with up to 240 receiving the COVID-19 vaccine and the remainder a control meningitis vaccine. AstraZeneca has a target to produce 3 billion doses this year and aims to produce over 200 million doses per month by April. Andrew Pollard, chief researcher on the Oxford vaccine trial, says that while most children don't get severely ill from COVID-19, "it is important to establish the safety and immune response to the vaccine in children and young people as some children may benefit from vaccination.'' Regulators in more than 50 countries have authorised widespread use of the Oxford vaccine, which is being produced and distributed by AstraZeneca, for use in people over the...read more...